SOURCE: Cypress Bioscience, Inc.

November 29, 2006 06:00 ET

Cypress Bioscience, Inc. to Present at CIBC World Markets 2nd Annual Mid & Small Cap "Best Ideas" Conference

SAN DIEGO, CA -- (MARKET WIRE) -- November 29, 2006 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Business Officer and Chief Financial Officer, will present at the CIBC World Markets 2nd Annual Mid and Small Cap "Best Ideas" Conference on Wednesday, November 29, 2006.

The CIBC conference is being held at the Millennium Broadway Hotel, New York, NY. Ms. Johnson is scheduled to present on Wednesday, November 29th at 2:15 p.m. Eastern Time.

Investors, analysts and the general public are invited to listen to a live audio broadcast of this presentation over the Internet. The broadcast can be accessed at

A replay of the presentation will be available at the same web address as well as on Cypress' website,

About Cypress Bioscience, Inc.

Cypress is committed to being the innovator and leader in providing products that improve the treatment of Functional Somatic Syndromes and other central nervous system conditions. Cypress' strategy involves acquiring/in-licensing undervalued central nervous system active compounds and developing them for new indications.

For more information about Cypress, please visit the Company's web site at

Contact Information

  • For additional information please contact:

    For Cypress Bioscience:
    Sabrina Martucci Johnson
    Executive VP, Chief Business Officer and Chief Financial Officer
    (858) 452-2323

    Cypress Bioscience, Inc.
    4350 Executive Drive
    Suite 325
    San Diego, California 92121